[1] |
YANG Min, PAN Yansha, ZHANG Changling, CHEN Hongying, GUO Qulian, LIU Wenjun.
Correlation analysis of baseline data, early treatment response and prognosis in children with acute lymphoblastic leukemia
[J]. Tianjin Medical Journal, 2024, 52(9): 954-958.
|
[2] |
JI Xiaojuan, HAN Hao, ZHANG Lixia.
Pathogenic bacteria distribution, drug resistance changes and risk factors of death in patients with acute myeloid leukemia complicated with bloodstream infection
[J]. Tianjin Medical Journal, 2024, 52(2): 167-171.
|
[3] |
ZHOU Xinyu, LI Jingmin, ZHANG Ting, JIA Xiuhong.
Study on the mechanism of luteolin reversing multidrug resistance in leukemia K562/ADR cells
[J]. Tianjin Medical Journal, 2023, 51(12): 1321-1325.
|
[4] |
CHEN Zhe, ZHANG Ling, YUAN Xiaofei, LIU Jie, GAO Binghua, ZHANG Bin.
Role of IRAK1/TRAF6 pathway in the occurrence and development of acute myeloid leukemia
[J]. Tianjin Medical Journal, 2022, 50(3): 225-230.
|
[5] |
LI Yan, ZHANG Jing-nan, ZHANG Jin, SHI Wen-hua, YE Shu-mei, DENG Xiu-ling, HU Rui-ping, XUE Hui-ting.
Cytotoxic effects of spiruline platensis polysaccharides on acute T lymphocyte leukemia
[J]. Tianjin Medical Journal, 2021, 49(4): 337-341.
|
[6] |
PENGYan-hui, DUANZhi, LITao△.
Effects and mechanism of luteolin on the proliferation and apoptosis of K562 cells
[J]. Tianjin Medical Journal, 2021, 49(3): 236-241.
|
[7] |
YANG You, ZHONG Fang-fang, HUANG Zhe, QIN Xiang, MA Wen-zhe, LIU Wen-jun.
Shuanghuanglian freeze-dried powder induced apoptosis of acute B cell lymphocytic leukemia cells (Nalm6) through inhibiting the MEK-ERK signaling pathway
[J]. Tianjin Medical Journal, 2021, 49(10): 1014-1019.
|
[8] |
MU Juan, LYU Hai-rong, LI Jing-yi, JIANG Yan-yu, ZHANG Rui, MENG Juan-xia, YUAN Ting , DENG Qi.
CD22 CAR-T salvage therapy for a refractory acute B lymphocytic leukemia patient with TP53#br#
positive mutation and short-term recurrence after remission from CD19 CAR-T therapy #br#
[J]. Tianjin Medical Journal, 2020, 48(4): 308-312.
|
[9] |
WANG Wen-jun, YU Yu, CUI Jiu-wei .
Expression of ERG gene in tumor and its clinical research progress
[J]. Tianjin Medical Journal, 2019, 47(2): 213-220.
|
[10] |
LIU Ying-xue, JIA Xiu-hong, YIN Hui-ying, ZHU Cong.
Effects of artesunate inhibiting the expression of FOXP3 on proliferation, apoptosis and
multidrug resistance of K562/ADR cells
[J]. Tianjin Medical Journal, 2019, 47(12): 1201-1205.
|
[11] |
LI Yu-ling, LIU Xiao-li, XU Na, TANG Jia-ming, LU Zi-yuan.
Clinical significance of p16 gene deletion in adult Philadelphia-negative B- lineage acute lymphoblastic leukemia
[J]. Tianjin Medical Journal, 2019, 47(11): 1170-1175.
|
[12] |
ZHANG Rui 1,LIU Dai-hong2△.
The challenge for allogeneic hematopoietic stem cell transplantation in acute leukemia/ myelodyplastic syndrom with TP53, TET2 or DNMT3A gene mutations
[J]. Tianjin Med J, 2018, 46(8): 837-841.
|
[13] |
NIU Hai-yue, CAO Qiu-ying, QI Wei-wei, WANG Yi-hao, JIANG Hui-juan, WANG Hua-quan, SHAO Zong-hong.
A case of blastic plasmacytoid dendritic cell neoplasm
[J]. Tianjin Med J, 2018, 46(8): 828-831.
|
[14] |
XU Jian-hui 1, LIU Xiao-shu2,ZHONG Yu-xia1,HE Ying-zhi 1,DU Jing-wen1,HUANG Yu-xian1,LI Yu-hua1.
The clinical observation of relapsed or refractory acute myeloid leukemia in patients with high CD117 expression but no FLT3-ITD mutation treated with sorafenib alone
[J]. Tianjin Med J, 2018, 46(8): 819-823.
|
[15] |
TENG Guang-shuai, WANG Ying-shao, XU Jing, DU Chen-xiao, WANG Yan, CHEN Ya-fang, SHENG Meng-yao, BAI Jiao-jiao, ZHANG Lei, ZHOU Yuan, YANG Feng-chun, BAI Jie.
Spectrum of gene mutation and clinical significance in myeloid malignancy patients with ASXL1 mutation
[J]. Tianjin Medical Journal, 2018, 46(12): 1295-1299.
|